The potential acquisition of Syqe Medical by Phillip Morris represents a significant strategic move for the tobacco giant, signaling its entry into the flourishing marijuana industry. With an initial investment of $130 million to support Syqe’s FDA approval process, followed by a possible $650 million acquisition, this deal can potentially make Syqe one of the largest cannabis companies globally. Moreover, Syqe’s innovative inhaler, utilizing raw cannabis inflorescence, could secure FDA approval, positioning the company as a trailblazer in the medical cannabis sector.
The new cannabis beverage boom isn’t really about replacing booze. It’s about replacing everything people…
Amber Senter co-founded Supernova Women, the organization that helped shape America’s first cannabis social equity…
The finding: states that legalized medical or recreational marijuana saw significant reductions in non-fatal opioid…
Eighty-eight percent. Let that sit for a moment. According to the latest nationwide polling from…
A story that once sounded like peak internet fantasy has taken a very real turn. …
Your June 2026 horoscopes brings a powerful mix of growth, reflection, and fresh opportunities. The…